Dr. Wasawat Sroithong, Investor Relations Officer at Medeze Group Public Company Limited (SET: MEDEZE),...
MEDEZE Outlines Future Plans for Clinical Trials and International Expansion, Eyes GMP Certification by 4Q26
Ms. Anchisa Lekpetch, Chief Accounting and Finance Officer, and Dr. Wasawat Sroithong, Investor Relations...
MEDEZE Aims to Promote Thailand as Asia’s Hub for ATMPs With Global Standard
Thailand’s Advanced Therapy Medicinal Products (ATMP) and cell banking sector is witnessing a key...
MEDEZE Focuses on Market Expansion against Geopolitical Headwinds in 1Q26
Medeze Group Public Company Limited (SET: MEDEZE) has released its financial results for the...
Medeze Sets Sights on One-Billion-Baht Revenue in 2026, Driving Growth via ATMPs and Strategic Partnerships
Medeze Group Public Company Limited (SET: MEDEZE) has announced an ambitious roadmap for 2026,...
MEDEZE Reports THB196 Million of Net Profit in 2025, Navigates Headwinds with Strategic Infra Investments for Future Growth
Medeze Group Public Company Limited (SET: MEDEZE) recently released its full-year 2025 financial results,...